Needle aponeurotomy offers a minimally invasive, office-based approach for the treatment of Dupuytren’s disease. Many patients are able to obtain almost immediate full correction of both metacarpophalangeal joint (MCPJ) and proximal interphalangeal joint (PIPJ) contractures. Compared to open fasciectomy, patients undergoing NA experience earlier and higher rates of recurrence; however, almost 50% of patients are able to achieve long-lasting results. Predictors of better outcomes include older patients at the time of treatment and less severe flexion contractures. NA was also more effective for the correction of contractures at the MCPJ compared to the PIPJ, both immediately and in the long term. Complications of NA are rare and most commonly include skin tears, superficial infections, and transient paresthesias that can be managed conservatively. Adjunctive procedures such as concomitant steroid injections or autologous fat grafting at the time of NA have shown promise but require more evidence to support their regular use. From both a patient and societal perspective, NA is the most cost-effective treatment strategy for Dupuytren’s disease. With high rates of patient satisfaction, needle aponeurotomy should be discussed and considered as a potential treatment option for patients with primary or recurrent Dupuytren’s contractures.